Cargando…
TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma
TP53 has been proved to be associated with cytotoxic T-cell induced apoptosis, however, the association between TP53 and the benefit of immunotherapy in melanoma has not been studied. In the present study, we examined the relationship between TP53 mutation and response to CTLA-4 blockade in metastat...
Autores principales: | Xiao, Wenjing, Du, Nan, Huang, Taoyuan, Guo, Jinan, Mo, Xingkui, Yuan, Tao, Chen, Yong, Ye, Ting, Xu, Chunwei, Wang, Wenxian, Wang, Guoqiang, Cai, Shangli, Chen, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020711/ https://www.ncbi.nlm.nih.gov/pubmed/29793878 http://dx.doi.org/10.1016/j.ebiom.2018.05.019 |
Ejemplares similares
-
Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancer
por: Gong, Zheng, et al.
Publicado: (2023) -
Germline mutation in the TP53 gene in uveal melanoma
por: Hajkova, Nikola, et al.
Publicado: (2018) -
TP53 structural variants in metastatic prostatic carcinoma
por: Sirohi, Deepika, et al.
Publicado: (2019) -
TP53 allele loss, mutations and expression in malignant melanoma.
por: Flørenes, V. A., et al.
Publicado: (1994) -
TP53 and its Regulatory Genes as Prognosis of Cutaneous Melanoma
por: Khan, Safir Ullah, et al.
Publicado: (2023)